NO974529D0 - Innretning for tilförselen av alfuzosin gjennom huden - Google Patents

Innretning for tilförselen av alfuzosin gjennom huden

Info

Publication number
NO974529D0
NO974529D0 NO974529A NO974529A NO974529D0 NO 974529 D0 NO974529 D0 NO 974529D0 NO 974529 A NO974529 A NO 974529A NO 974529 A NO974529 A NO 974529A NO 974529 D0 NO974529 D0 NO 974529D0
Authority
NO
Norway
Prior art keywords
alfuzosin
skin
delivery
Prior art date
Application number
NO974529A
Other languages
English (en)
Other versions
NO974529L (no
Inventor
Franz-Josef Braun
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of NO974529D0 publication Critical patent/NO974529D0/no
Publication of NO974529L publication Critical patent/NO974529L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
NO974529A 1995-03-31 1997-09-30 Innretning for tilförselen av alfuzosin gjennom huden NO974529L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/414,188 US5614210A (en) 1995-03-31 1995-03-31 Transdermal device for the delivery of alfuzosin
PCT/US1996/001919 WO1996030020A1 (en) 1995-03-31 1996-02-15 Transdermal device for the delivery of alfuzosin

Publications (2)

Publication Number Publication Date
NO974529D0 true NO974529D0 (no) 1997-09-30
NO974529L NO974529L (no) 1997-12-01

Family

ID=23640336

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974529A NO974529L (no) 1995-03-31 1997-09-30 Innretning for tilförselen av alfuzosin gjennom huden

Country Status (8)

Country Link
US (1) US5614210A (no)
EP (1) EP0817633A1 (no)
JP (1) JPH11502836A (no)
KR (1) KR19980703627A (no)
CA (1) CA2215256A1 (no)
HU (1) HUP9802299A3 (no)
NO (1) NO974529L (no)
WO (1) WO1996030020A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194281T1 (de) * 1994-09-14 2000-07-15 Minnesota Mining & Mfg Matrix für transdermale wirkstofffreisetzung
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
JP4567998B2 (ja) * 2004-03-22 2010-10-27 コスメディ製薬株式会社 親水性粘着剤を用いた親水性皮膚外用粘着剤組成物および親水性貼付剤
US20090214643A1 (en) * 2005-07-19 2009-08-27 Franklin Amie E Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
MX2022005168A (es) 2019-11-06 2022-06-08 Smartech Topical Inc Formulaciones topicas de inhibidores de la ciclooxigenasa y su uso.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT610737A (no) * 1955-11-18 1900-01-01
US3842059A (en) * 1971-02-22 1974-10-15 M Chiang Acrylate and methacrylate terminated polystyrene macromolecular monomers having a substantially uniform molecular weight distribution
US3786116A (en) * 1972-08-21 1974-01-15 Cpc International Inc Chemically joined,phase separated thermoplastic graft copolymers
US4732808A (en) * 1985-11-14 1988-03-22 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive sheet material
US4737559A (en) * 1986-05-19 1988-04-12 Minnesota Mining And Manufacturing Co. Pressure-sensitive adhesive crosslinked by copolymerizable aromatic ketone monomers
EP0573581A4 (en) * 1991-02-26 1994-06-29 Arc 1 Inc Compositions and methods of treatment of sympathetically maintained pain
FR2694495B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Préparation pharmaceutique transdermique contenant de l'alfuzosine.

Also Published As

Publication number Publication date
KR19980703627A (ko) 1998-12-05
CA2215256A1 (en) 1996-10-03
NO974529L (no) 1997-12-01
WO1996030020A1 (en) 1996-10-03
JPH11502836A (ja) 1999-03-09
EP0817633A1 (en) 1998-01-14
US5614210A (en) 1997-03-25
HUP9802299A2 (hu) 1999-02-01
HUP9802299A3 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
NL1003300A1 (nl) Implanteerbare therapeutische inrichting.
DE820258T1 (de) Substanzabgabevorrichtung
DE69629534D1 (de) Gewebe-Aufzeigevorrichtung
DE69623722T2 (de) Blutbehandlungsgerät
DE69638138D1 (de) S endoluminarspiral-abgabesystem
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
DE69633957D1 (de) Implantierbares Gerät zur Antitachykardierierung
DK0747069T3 (da) Implanterbar medicinsk anordning
NO981325D0 (no) Inhaleringsanordning
DK0757905T3 (da) Nasaldilatatorindretning
DE69614680D1 (de) Implantierbare osteosynthesevorrichtung
DE69606405D1 (de) Inhalationsgerät
DE69622553D1 (de) Flüssiges urethan enthaltendes addukt
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
FI964619A (fi) Epilepsialääkkeiden iholle annostelu
NO974529D0 (no) Innretning for tilförselen av alfuzosin gjennom huden
EE9700207A (et) Teraapias kasutatavad bitsüklilised amidiini derivaadid
DK0957961T3 (da) Inhalationshjælpeindretning
DE29517060U1 (de) Stimulationseinrichtung
DE59610423D1 (de) Partikulare arzneiform
DE29516634U1 (de) Atemtherapiegerät
DE59602440D1 (de) Liefervorrichtung
DE59608075D1 (de) Intrakorporales behandlungssystem
KR970008147U (ko) 전신 마사지 장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application